Pharmacy news

• FDA Approves Hovilpri for Refractory HSV Lesions

  14-10-2026 13:26 via Pharmacy Practice News
  
  Originally published by our sister publication Infectious Disease Special EditionBy Meaghan Lee CallaghanThe FDA has approved pritelivir (Hovilpri, Asahi Kasei) for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection that is refractory (with or without documented resistance) to treatment with acyclovir, famciclovir, or valacyclovir in immunocompromised adults.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller;
  
  Read more

• The Backup for Drug Shortages Is Required by Law to Arrive Late

  14-10-2026 13:15 via Pharmacy Practice News
  
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }©McMahon Group.By Dalbir BainsAmerica's backup supply of sterile drugs is required by law to arrive late.Start with the scoreboard. ASHP counted
  
  Read more

• Medicaid Makes the Case for Food as Medicine

  14-10-2026 04:41 via Pharmacy Practice News
  
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawMedically tailored meals delivered to high-risk Medicaid members were associated with 31% fewer hospitalizations, 20% fewer emergency department visits, and $3,433 lower total healthcare costs per person, in the largest real-world evaluation of the intervention to date.The cost reductions offset 98% of program costs, and among participants with cardiovascular disease, kidney disease, diabetes, depression, or h
  
  Read more

Follow @newsl_pharmacy on Twitter!